Poolbeg Pharma Share Price | |
---|---|
Price | 13.75 |
Bid | 13.60 |
Ask | 13.90 |
Change | 0.15 (1.10%) |
Volume | 2,021,842 |
Open | 13.60 |
High | 13.75 |
Low | 13.75 |
Prev. Close | 13.60 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 500.00m |
Market Capitalisation | £68.75m |
Market Size | 30,000 |
52 Week High | 15.70 |
52 Week High Date | 07-May-2024 |
52 Week Low | 6.38 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 79 |
---|---|
Vol. Sold | 217,950 |
Sold Value | £29.86k |
Vol. Bought | 1,344,008 |
Bought Value | £184.80k |
PE Ratio | -14.62766 |
Earnings | -0.94 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
10-May-24 | 16:35:21 | 13.75 | 20,000 | Unknown* | 13.60 | 13.90 | 2,750 | UT Uncrossing Trade |
10-May-24 | 16:25:18 | 13.80 | 75,000 | Buy* | 13.60 | 13.90 | 10.35k | O Ordinary |
10-May-24 | 16:25:11 | 13.80 | 75,000 | Buy* | 13.60 | 13.90 | 10.35k | O Ordinary |
10-May-24 | 16:20:02 | 13.852 | 18,363 | Buy* | 13.60 | 13.90 | 2,544 | O Ordinary |
10-May-24 | 16:08:05 | 13.80 | 100,000 | Buy* | 13.60 | 13.90 | 13.80k | O Ordinary |
10-May-24 | 16:05:12 | 13.735 | 10,000 | Sell* | 13.70 | 13.90 | 1,374 | O Ordinary |
10-May-24 | 16:01:38 | 13.80 | 30,000 | Unknown* | 13.70 | 13.90 | 4,140 | O Ordinary |
10-May-24 | 16:00:32 | 13.90 | 500 | Buy* | 13.70 | 13.90 | 69.50 | O Ordinary Trade was executed as an SI |
10-May-24 | 15:56:55 | 13.84 | 185 | Sell* | 13.80 | 13.90 | 25.60 | O Ordinary |
10-May-24 | 15:47:11 | 13.84 | 1,711 | Sell* | 13.80 | 13.90 | 236.80 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
22-Feb-24 | 21-Feb-24 | Buy | Jeremy Skillington held the position of CEO at the time of this trade.Jeremy Skillington | 10.80 | GBX | 154,764 | 1,028,261 |
19-Feb-24 | 19-Feb-24 | Buy | Cathal Friel held the position of Executive Chairman at the time of this trade.Cathal Friel | 11.68 | GBX | 830,000 | 37,219,757 |
06-Oct-22 | 05-Oct-22 | Buy | Jeremy Skillington held the position of CEO at the time of this trade.Jeremy Skillington | 4.78 | GBX | 718,733 | 718,733 |
19-Jul-21 | 19-Jul-21 | Notification of Holding | Patrick J Ashe held the position of Independent Non-Executive Director at the time of this trade.Patrick J Ashe | 0.00 | 0 | 263,147 | |
19-Jul-21 | 19-Jul-21 | Notification of Holding | Cathal Friel held the position of Non-Executive Chairman at the time of this trade.Cathal Friel | 0.00 | 0 | 36,389,757 |
Welcome to Poolbeg Pharma plc which is listed on AIM (AIM:POLB). Keep up to date with our performance & latest news